Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Gene | BRIP1 |
Variant | K52R |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | BRIP1 K52R lies within the helicase ATP-binding domain of the Brip1 protein (UniProt.org). K52R confers a loss of function to the Brip1 protein as demonstrated by loss of helicase and ATPase activity (PMID: 14983014, PMID: 16116421) and failure to confer resistance to interstrand crosslinking agents in a BRIP1-deficient cell line in culture (PMID: 33619228). |
Associated Drug Resistance | |
Category Variants Paths |
BRIP1 mutant BRIP1 inact mut BRIP1 K52R |
Transcript | NM_032043.3 |
gDNA | chr17:g.61859846T>C |
cDNA | c.155A>G |
Protein | p.K52R |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_047436899.1 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525334.3 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525336.2 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_047436903.1 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
NM_032043.2 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525332 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525336.3 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_047436892.1 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525335.4 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_047436893.1 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_047436902.1 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
NM_032043 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_047436897.1 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525339 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_047436891.1 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
NM_032043.3 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525340.3 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525334.2 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525335 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525341 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525333.3 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525333.4 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_047436894.1 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525340 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525337 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525332.4 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525340.4 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525332.3 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_047436901.1 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525334 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525335.3 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_047436900.1 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_047436895.1 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525336 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525341.3 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_047436896.1 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525341.4 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525339.3 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525333 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_047436904.1 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525337.2 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
XM_011525339.4 | chr17:g.61859846T>C | c.155A>G | p.K52R | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
BRIP1 K52R | Advanced Solid Tumor | sensitive | CX-5461 | Preclinical - Cell culture | Actionable | In a preclinical study, CX-5461 inhibited survival of transformed cells expressing BRIP1 K52R in culture (PMID: 32542039). | 32542039 |